Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)

Market Cap	5.29B +18.4%
Revenue (ttm)	302.92M -8.3%
Net Income	6.35M +956.5%
EPS	0.01 +1,077.0%
Shares Out	1.29B
PE Ratio	833.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,189,270
Average Volume	41,256,666
Open	4.390
Previous Close	4.110
Day's Range	4.020 - 4.390
52-Week Range	2.330 - 10.280
Beta	0.54
RSI	30.80
Earnings Date	Apr 22, 2026

About SHE:300111

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 331
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300111

Financial Performance

In 2024, SHE:300111's revenue was 330.37 million, a decrease of -2.38% compared to the previous year's 338.42 million. Earnings were 7.83 million, a decrease of -64.01%.